Risk factors
Supernus Pharmaceuticals (SUPN) risk factors
Item 1A of every Supernus Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next.
- FY2025 10-K risk factors
72 risks, 15 new, 15 dropped, 23 reworded since the prior year. New risks highlight commercial dependence on key products like ZURZUVAE, ONAPGO supply constraints, and recent executive orders impacting pricing.
Filed Mar 02, 2026 - FY2024 10-K risk factors
72 risks. This is a new filing without prior year risk factors. The risk profile is dominated by reliance on three major distributors for product sales, competition from generic drug manufacturers, and regulatory dependencies for product approvals and post-marketing commitments.
Filed Feb 25, 2025